Opportunity Information: Apply for PA 14 250
Apply for PA 14 250
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Lab to Marketplace Tools for Brain and Behavioral Research (R43/R44)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.173 Research Related to Deafness and Communication Disorders 93.242 Mental Health Research Grants.
- This funding opportunity was created on Jun 5, 2014 and posted on Jun 5, 2014.
- Applicants must submit their applications by May 7, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Small businesses.
- See complete announcement for full details.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Lab to Marketplace Tools for Brain and Behavioral Research (R43/R44) funding opportunity (PA-14-250) is an NIH Small Business Innovation Research (SBIR) grant program designed to help move promising brain- and behavior-related research technologies out of academic or other noncommercial labs and into the commercial marketplace. The core problem it targets is common in research tool development: universities and other noncommercial developers often create highly innovative hardware, software, or biological tools, but those tools may remain difficult to adopt broadly because they are not packaged, documented, supported, or engineered for reliability at scale. As a result, the benefits of these technologies often stay confined to the original lab and close collaborators, and the tools can stagnate when ongoing maintenance and updates are hard to fund in a noncommercial setting.
This FOA aims to close that gap by supporting small businesses that will further develop these tools so they become robust, user-friendly, and broadly usable by the research community. The opportunity explicitly recognizes that commercialization typically forces tools to meet real-world expectations: stability, repeatability, ease of installation and use, good documentation, quality control, customer support, and a pathway for continuous improvement. In other words, the program is not just about inventing something new, but about transforming something that already shows scientific value into a product-grade tool that other researchers can adopt without needing insider knowledge from the original developers.
The scope of technologies includes three broad categories. First is hardware, such as instruments and devices used to measure or manipulate brain and behavioral function. Second is software, including computational models, informatics platforms, and data analytics methods that help researchers interpret neural and behavioral data. Third is wetware, which can include cell-free assays, bioactive agents, and imaging probes that enable or enhance experiments. Across all categories, the common theme is translation from lab prototype to market-ready research product, with development work likely centered on engineering improvements, usability enhancements, validation, reproducibility, packaging, and workflows that make the tool accessible to a wide range of users.
A key feature of the announcement is its emphasis on collaboration between the small business concern (SBC) and the original noncommercial tool developers. Because the original team often holds the deepest technical understanding, successful commercialization may require close coordination to transfer know-how, refine specifications, and ensure the commercial version preserves the scientific capabilities that made the tool valuable in the first place. The FOA notes that these partnerships can be structured in multiple ways, including arrangements with multiple program directors/principal investigators (PDs/PIs), which can help formalize shared leadership between academic inventors and company leads.
Administratively, this is a discretionary grant opportunity offered by the National Institutes of Health, using the SBIR mechanisms R43 and R44 (commonly associated with Phase I and Phase II SBIR awards). It falls under the health-related funding activity category and is tied to NIH missions relevant to brain and behavioral research, with CFDA listings that include research related to deafness and communication disorders (93.173) and mental health research grants (93.242). Eligibility is limited to small businesses, and there is no cost sharing or matching requirement stated in the provided data. The opportunity was posted June 5, 2014, and the final closing date listed is May 7, 2017, with an archive date of June 7, 2017, meaning it is no longer open but remains important as a reference model for similar NIH SBIR commercialization-focused programs.
In practical terms, applications under this FOA would be expected to present a clear plan for taking an existing, research-validated technology and performing the additional R&D needed to turn it into a reliable, supported commercial tool. Competitive proposals would typically need to explain the unmet need in the broader research community, the specific limitations of the current noncommercial version, the technical and product-development steps to improve robustness and usability, and a plausible commercialization path that aligns with the missions of the sponsoring NIH Institutes and Centers. The overall goal is to ensure that taxpayer-funded innovations in neuroscience and behavioral research become widely accessible, maintainable, and continually improved through sustainable commercial distribution rather than remaining boutique tools used only by a small circle of experts.
FAQs: Lab to Marketplace Tools for Brain and Behavioral Research (R43/R44) - PA-14-250
What is the PA-14-250 funding opportunity?
PA-14-250, titled Lab to Marketplace Tools for Brain and Behavioral Research (R43/R44), is an NIH Small Business Innovation Research (SBIR) funding opportunity intended to help move promising brain- and behavior-related research tools from noncommercial settings (such as universities and academic labs) into the commercial marketplace.
What problem is this FOA trying to solve?
The FOA targets a common gap in research tool development: innovative tools are often created in academic or other noncommercial labs, but they can be hard for the broader research community to adopt because they are not engineered, packaged, documented, supported, or maintained at a level expected for widespread use. Without commercialization, these tools may remain limited to the original lab and close collaborators and may stagnate due to limited funding for ongoing updates and maintenance.
What is the main goal of this SBIR program?
The main goal is to support small businesses in turning research-validated tools into robust, user-friendly, broadly usable products that the research community can adopt without relying on insider knowledge from the original developers. The emphasis is on making tools product-grade rather than simply inventing something entirely new.
Which SBIR mechanisms are used under this opportunity?
This opportunity uses NIH SBIR grant mechanisms R43 and R44, commonly associated with Phase I and Phase II SBIR awards.
Who is eligible to apply?
Eligibility is limited to small businesses (small business concerns, SBCs). The provided information does not indicate eligibility for academic institutions as direct applicants under this FOA, though collaboration with noncommercial developers is emphasized.
Does the opportunity require cost sharing or matching funds?
No cost sharing or matching requirement is stated in the provided information.
What kinds of technologies are within scope?
The FOA covers brain- and behavior-related research tools across three broad categories:
- Hardware: instruments and devices used to measure or manipulate brain and behavioral function.
- Software: computational models, informatics platforms, and data analytics methods for interpreting neural and behavioral data.
- Wetware: cell-free assays, bioactive agents, and imaging probes that enable or enhance experiments.
Is this program focused on new invention or productization of existing tools?
Based on the description provided, the program emphasizes translating an already valuable, research-validated tool into a market-ready product. It is specifically geared toward closing the gap between a working lab prototype and a reliable, supported tool that can be broadly adopted.
What types of development activities does the FOA prioritize?
The FOA highlights work typically required to make tools commercially usable, including engineering improvements, usability enhancements, validation, reproducibility, packaging, documentation, quality control, reliability at scale, workflow development, ease of installation and use, customer support readiness, and creating a pathway for continuous improvement.
Why does the FOA emphasize commercialization for research tools?
The FOA explicitly recognizes that commercialization often forces tools to meet real-world expectations such as stability, repeatability, usability, documentation quality, quality control, and support. These attributes are often difficult to sustain in noncommercial environments where ongoing maintenance and updates can be hard to fund.
Is collaboration with the original noncommercial developers expected or encouraged?
Yes. A key feature of the announcement is its emphasis on collaboration between the small business and the original noncommercial tool developers. The rationale is that the original developers often have the deepest technical understanding, and transferring know-how and refining specifications can be essential to preserving the tool's scientific capabilities while making it commercially robust.
Can the partnership include shared leadership between academic inventors and company leads?
Yes. The FOA notes that partnerships can be structured in multiple ways, including arrangements with multiple program directors/principal investigators (PDs/PIs), which can help formalize shared leadership between academic and company participants.
What would a practical, competitive application generally be expected to include?
Based on the information provided, applications would be expected to present a clear plan to take an existing, research-validated technology and perform additional R&D to turn it into a reliable, supported commercial tool. Competitive proposals would typically explain:
- The unmet need in the broader research community
- Limitations of the current noncommercial (prototype) version
- Specific technical and product-development steps to improve robustness and usability
- A plausible commercialization path aligned with NIH missions relevant to brain and behavioral research
What NIH missions and research areas is this opportunity tied to?
The opportunity is described as health-related and tied to NIH missions relevant to brain and behavioral research. The provided information lists CFDA areas that include research related to deafness and communication disorders (93.173) and mental health research grants (93.242).
When was this funding opportunity posted, and is it still open?
The opportunity was posted on June 5, 2014. The final closing date listed is May 7, 2017, and the archive date is June 7, 2017. Based on those dates, it is no longer open, but it may still be useful as a reference model for similar NIH SBIR programs.
What is the overarching public benefit described for this program?
The program aims to ensure that taxpayer-funded innovations in neuroscience and behavioral research become widely accessible, maintainable, and continually improved through sustainable commercial distribution, rather than remaining boutique tools used only by a small circle of experts.
Is this described as a discretionary grant opportunity?
Yes. The provided information describes it as a discretionary grant opportunity offered by the National Institutes of Health.
What does "Lab to Marketplace" mean in the context of this FOA?
In this context, "Lab to Marketplace" refers to the process of taking a tool that has demonstrated scientific value in a lab setting and investing the engineering, validation, packaging, documentation, and support work needed to make it a dependable, broadly adoptable product available to the wider research community.
Browse more opportunities from the same category: Health
Next opportunity: Model Approaches Phase II Systems Expansion Grants
Previous opportunity: Organic Certification Cost Share Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 14 250
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 14 250) also looked into and applied for these:
| Funding Opportunity |
|---|
| State Systems Development Initiative Grant Program Apply for HRSA 15 002 Funding Number: HRSA 15 002 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| RWANDA HEALTH SYSTEMS STRENGTHENING (RHSS) ACTIVITY Apply for RFA69614000001 Funding Number: RFA69614000001 Agency: Rwanda USAID Kigali Category: Health Funding Amount: $24,900,000 |
| Statewide Peer Network Development Program for Recovery and Resiliency Grants (Short Title Statewide Peer Networks for R Apply for SM 14 023 Funding Number: SM 14 023 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $100,000 |
| Limited Competition Large Scale Collaborative Project Award Renewals (U54) Apply for RFA GM 15 003 Funding Number: RFA GM 15 003 Agency: National Institutes of Health Category: Health Funding Amount: $5,000,000 |
| Developing and Improving Institutional Animal Resources (G20) Apply for PAR 14 251 Funding Number: PAR 14 251 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Specialized Alcohol Research Centers (P50) Apply for RFA AA 15 001 Funding Number: RFA AA 15 001 Agency: National Institutes of Health Category: Health Funding Amount: $1,800,000 |
| Comprehensive Alcohol Research Centers (P60) Apply for RFA AA 15 002 Funding Number: RFA AA 15 002 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| NIH StrokeNet Small Business Innovation Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U44) Apply for PAR 14 252 Funding Number: PAR 14 252 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention Infrastructure Resource Access (X01) Apply for PAR 14 253 Funding Number: PAR 14 253 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| 2014 PPHF 2014 Cooperative Agreements to Implement the National Strategy for Suicide Prevention (Short Title National Strategy Grants) (PPHF 2014) Apply for SM 14 016 Funding Number: SM 14 016 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $470,000 |
| HLA and KIR Region Genomics in Immune Mediated Diseases (U01) Apply for RFA AI 14 012 Funding Number: RFA AI 14 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HLA and KIR Region Genomics in Immune Mediated Diseases (U19) Apply for RFA AI 14 013 Funding Number: RFA AI 14 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Cooperative Agreement to Support Navigators in Federally facilitated and State Partnership Marketplaces Apply for CA NAV 14 002 Funding Number: CA NAV 14 002 Agency: CMS Consumer Information Insurance Oversight Category: Health Funding Amount: Case Dependent |
| Advancing National Public Health Institutes Globally Apply for CDC RFA GH14 1419 Funding Number: CDC RFA GH14 1419 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| NIOSH Support for Conferences and Scientific Meetings (R13) Apply for PAR 14 246 Funding Number: PAR 14 246 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $20,000 |
| Research Supplements for Aging Research on Health Disparities (Admin Supp) Apply for PA 14 256 Funding Number: PA 14 256 Agency: National Institutes of Health Category: Health Funding Amount: $62,500 |
| Training Seminars on Safe Medicine Apply for NDRFP14 05 Funding Number: NDRFP14 05 Agency: U.S. Mission to India Category: Health Funding Amount: $14,000 |
| Mentored Career Development Award to Build Research Capacity in Global Mental Health (K01) Apply for RFA MH 15 700 Funding Number: RFA MH 15 700 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01) Apply for RFA MH 15 600 Funding Number: RFA MH 15 600 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Severe Combined Immunodeficiency (SCID) Newborn Screening Implementation Program Apply for HRSA 14 139 Funding Number: HRSA 14 139 Agency: Health Resources and Services Administration Category: Health Funding Amount: $2,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 14 250", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.